Roche To Work On Reversing English Funding Rejection For SMA Drug

But Tecentriq Gets NICE Thumbs Up For NSCLC

 
• By Neena Brizmohun
  
Pile of British money pounds sterling new one pound coins GBP in four piles close-up with NHS above. Rising cost of National Health Service concept UK
Roche needs to offer a price for Evrysdi that is cost-effective for the NHS • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from United Kingdom

More from Europe